top of page

Search


THE HIDDEN CAUSES OF PERSISTENT FATIGUE: A PHYSICIAN’S GUIDE TO OVERLOOKED METABOLIC AND ENDOCRINE DISORDERS
Chronic fatigue often signals hidden metabolic or endocrine disorders. Learn the overlooked causes—from thyroid and iron issues to insulin resistance and mitochondria.

David S. Klein, MD FACA FACPM
Dec 24, 20254 min read


Surgery, Anesthesia and GLP-1 Weight Loss Medicines: The Unseen Danger
If you are preparing for surgery, one of the most important safety steps is to inform your surgeon and anesthesia team if you are taking a GLP-1 medication. These include well-known names such as Ozempic®, Wegovy®, Mounjaro®, Zepbound®, Rybelsus®, Trulicity®, Victoza®, Saxenda®, Byetta®, and Bydureon®. While these drugs provide significant benefits for weight loss and diabetes management, they can also delay stomach emptying—a normal part of their mechanism of action. In ever

David S. Klein, MD FACA FACPM
Dec 16, 20256 min read


Essential Vitamins and Supplements for Liver Health: Managing Fatty Liver Disease MASLD
Managing fatty liver disease MASLD requires a comprehensive approach. Vitamins and supplements can support liver health by reducing oxidative stress, improving metabolism, and lowering inflammation. However, they are part of a broader strategy that includes diet, exercise, and medical care.

David S. Klein, MD FACA FACPM
Dec 11, 20255 min read


Have a Happy Holiday: Detox Essentials
Detoxification is often misunderstood as a fad, yet it remains a central physiological process essential for human survival. The holiday season—marked by stress, alcohol consumption, disrupted sleep, and poor dietary choices—places a substantial metabolic burden on the liver, gallbladder, kidneys, lungs, and intestinal tract. This blog outlines the science behind the body’s three-phase detox pathway and explains how targeted nutritional support can enhance natural clearance m

David S. Klein, MD FACA FACPM
Dec 2, 202510 min read


Zepbound® (tirzepatide) and Menopausal Weight Loss: A Promising Ally for a Challenging Transition
Menopause is a time of profound metabolic transition, and for many women, weight gain becomes an unwelcome companion despite disciplined efforts with diet and exercise. As estrogen levels fall, resting metabolism slows, visceral fat accumulates, and insulin sensitivity declines—creating a perfect storm that resists traditional weight-loss approaches. Zepbound® (tirzepatide) offers a meaningful breakthrough for women facing these challenges. By activating both GIP and GLP-1 re

David S. Klein, MD FACA FACPM
Nov 25, 20253 min read


Understanding the Connection Between Hypothyroidism and Atherosclerotic Heart Disease
Hypothyroidism is far more than a problem of low metabolism—it’s a quiet amplifier of vascular disease. By addressing thyroid imbalance, we not only restore energy and mental clarity but also protect the heart from atherosclerotic injury. Managing these conditions together yields the best outcomes for long-term vitality and longevity.

David S. Klein, MD FACA FACPM
Nov 13, 20255 min read


The Link Between Fructose Beverages and Non-Alcoholic Fatty Liver Disease
Understanding the connection between fructose-containing beverages and fatty liver disease empowers people to make informed choices. By reducing sugary drink intake and adopting healthier habits, it is possible to protect the liver and improve overall health.

David S. Klein, MD FACA FACPM
Nov 10, 20255 min read


Uncovering the Science: How Berberine Unleashes Its Healing Potential: Diabetes Control, Cancer Prevention and Weight Loss
Berberine, a natural compound from several plants, is gaining much attention in health circles for its impressive medicinal properties. This bright yellow alkaloid, used for centuries in ancient Chinese and Ayurvedic medicine, is now the focus of modern research. It may play a significant role in enhancing metabolic health and supporting cardiovascular wellness, offering a profound perspective on holistic health.

David S. Klein, MD FACA FACPM
Oct 21, 20255 min read


Zepbound (Tirzepatide) for Weight Loss and Obstructive Sleep Apnea: Approved by Many Medicare Prescription Plans
Zepbound is a different type of GLP-1 used to treat weight problems. It is an advancement over the Wegovy-Ozempic class in that it is a dual receptor acting agent.
More so, it is covered under many Medicare Prescription plans in patients that suffer from sleep apnea (obstructive sleep apnea) after documentation with sleep study.

David S. Klein, MD FACA FACPM
Oct 17, 20254 min read


Lower Your Serum Insulin Level to Reduce the Risk of Cancer, Diabetes, and Live Longer.
Lower Your Serum Insulin Level to Reduce the Risk of Cancer, Diabetes, and Live Longer

David S. Klein, MD FACA FACPM
Oct 1, 20257 min read
bottom of page




